C-TRI Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 222


  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

C-TRI General Information


HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Parent Company
HLB Pharmaceutical
Former Stock Listing
Corporate Office
  • 10th floor, Kowoon Institute of Technology Innovation
  • Suwon University, Gyeonggangro, Gyeonggi-do
  • Hwaseong, 445-743
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C-TRI Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.

Request a free trial

C-TRI Executive Team (2)

Name Title Board Seat Contact Info
WanJoo Kim Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

C-TRI Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C-TRI Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.

Request a free trial

C-TRI Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sears Pharmaceuticals (Rights to Rosu Duo) 24-Nov-2023 000000000 Other Pharmaceuticals and Biotechnology 000000 00
Verismo Therapeutics 27-Apr-2021 0000 00000 0000 Biotechnology
SuperTrans Medical 07-Apr-2020 Corporate 000 Pharmaceuticals
To view C-TRI’s complete investments history, request access »


  • When was C-TRI founded?

    C-TRI was founded in 1998.

  • Who is the founder of C-TRI?

    Wan-joo Kim is the founder of C-TRI.

  • Who is the CEO of C-TRI?

    WanJoo Kim is the CEO of C-TRI.

  • Where is C-TRI headquartered?

    C-TRI is headquartered in Hwaseong, South Korea.

  • What is the size of C-TRI?

    C-TRI has 222 total employees.

  • What industry is C-TRI in?

    C-TRI’s primary industry is Drug Discovery.

  • Is C-TRI a private or public company?

    C-TRI is a Private company.

  • What is C-TRI’s current revenue?

    The current revenue for C-TRI is 00000.

  • Who are C-TRI’s investors?

    Dae Hwa Pharm, Hyundai Venture Investment Corporation, and SL Investment have invested in C-TRI.

  • When was C-TRI acquired?

    C-TRI was acquired on 17-Oct-2019.

  • Who acquired C-TRI?

    C-TRI was acquired by HLB Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »